Insider Selling: Trulieve Cannabis (NYSE:TRLV) CEO Sells $3,218,600.00 in Stock

Trulieve Cannabis Corp. (NYSE:TRLV) CEO Kim Rivers sold 380,000 shares of the firm’s stock in a transaction dated Tuesday, June 23rd. The shares were sold at an average price of $8.47, for a total transaction of $3,218,600.00. Following the sale, the chief executive officer directly owned 2,313,724 shares in the company, valued at approximately $19,597,242.28. The trade was a 14.11% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trulieve Cannabis Price Performance

Trulieve Cannabis stock opened at $8.93 on Friday. Trulieve Cannabis Corp. has a one year low of $3.50 and a one year high of $13.28.

Trulieve Cannabis News Summary

Here are the key news stories impacting Trulieve Cannabis this week:

• Negative Sentiment: CEO Kim Rivers sold 136,811 shares for about $1.2 million, adding to concerns that management may be taking advantage of the stock’s recent strength. Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year
• Neutral Sentiment: Multiple reports highlighted additional CEO stock sales from earlier in the week, including 300,000 shares on June 25 and 400,000 shares on June 24, reinforcing the theme of heavy insider selling. Insider Selling: Trulieve Cannabis (NYSE:TRLV) CEO Sells $2,451,000.00 in Stock
• Neutral Sentiment: Trulieve announced the planned termination of an executive automatic securities disposition plan, which may simply reflect a change in future insider-sale mechanics rather than a direct change in fundamentals. Trulieve Announces Planned Termination of Executive Automatic Securities Disposition Plan
• Neutral Sentiment: Investor commentary also noted Trulieve among “promising” or “best” cannabis stocks to watch, but these mentions were broad sector pieces and did not include a company-specific catalyst. Promising Cannabis Stocks To Follow Today – June 26th

Analyst Ratings Changes

A number of equities analysts recently issued reports on TRLV shares. Zacks Research raised shares of Trulieve Cannabis to a “hold” rating in a report on Thursday, June 18th. Weiss Ratings initiated coverage on Trulieve Cannabis in a research note on Tuesday, June 16th. They issued a “sell (d-)” rating for the company. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Reduce”.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.